255 related articles for article (PubMed ID: 37316687)
21. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.
Ulndreaj A; Wang M; Misaghian S; Paone L; Sigal GB; Stengelin M; Campbell C; Van Nynatten LR; Soosaipillai A; Ghorbani A; Mathew A; Fraser DD; Diamandis EP; Prassas I
Clin Chem Lab Med; 2022 Jun; 60(7):1116-1123. PubMed ID: 35475723
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 infection and increasing autoimmune disorders among ICU-hospitalized COVID-19 patients.
Mosavat A; Mirhosseini A; Shariati A; Mohareri M; Valizadeh N; Mohammadi FS; Shamsian SAA; Jafari Rad M; Rezaee SA
Int J Rheum Dis; 2023 Nov; 26(11):2151-2156. PubMed ID: 37578135
[TBL] [Abstract][Full Text] [Related]
23. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.
Adiguzel Y; Mahroum N; Muller S; Blank M; Halpert G; Shoenfeld Y
Clin Rev Allergy Immunol; 2023 Aug; 65(2):206-230. PubMed ID: 37505416
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases.
Lakota K; Perdan-Pirkmajer K; Hočevar A; Sodin-Semrl S; Rotar Ž; Čučnik S; Žigon P
Front Immunol; 2020; 11():611318. PubMed ID: 33574819
[TBL] [Abstract][Full Text] [Related]
25. Emerging Roles of Coronavirus in Autoimmune Diseases.
Zhou SY; Zhang C; Shu WJ; Chong LY; He J; Xu Z; Pan HF
Arch Med Res; 2021 Oct; 52(7):665-672. PubMed ID: 33875273
[TBL] [Abstract][Full Text] [Related]
26. Case Report: Systemic Sclerosis After Covid-19 Infection.
Fineschi S
Front Immunol; 2021; 12():686699. PubMed ID: 34262566
[TBL] [Abstract][Full Text] [Related]
27. No Evidence for Myocarditis or Other Organ Affection by Induction of an Immune Response against Critical SARS-CoV-2 Protein Epitopes in a Mouse Model Susceptible for Autoimmunity.
Ignatz RM; Zirkenbach VA; Kaya M; Stroikova V; Öttl R; Frey N; Kaya Z
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373021
[TBL] [Abstract][Full Text] [Related]
28. [Importance of autoimmunity induced by SARS-CoV-2 and development of post-vaccination autoimmune diseases].
Montaño-Armendáriz N; Zamudio-Cuevas Y; Fernández-Torres J; Martínez-Flores K; Luján-Juárez IA
Rev Alerg Mex; 2023 Jan; 69(2):78-88. PubMed ID: 36928248
[TBL] [Abstract][Full Text] [Related]
29. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
30. Insights into new-onset autoimmune diseases after COVID-19 vaccination.
Guo M; Liu X; Chen X; Li Q
Autoimmun Rev; 2023 Jul; 22(7):103340. PubMed ID: 37075917
[TBL] [Abstract][Full Text] [Related]
31. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma.
Matucci-Cerinic M; Hughes M; Taliani G; Kahaleh B
Autoimmun Rev; 2021 Oct; 20(10):102899. PubMed ID: 34274540
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies during infectious diseases: Lessons from malaria applied to COVID-19 and other infections.
Rivera-Correa J; Rodriguez A
Front Immunol; 2022; 13():938011. PubMed ID: 36189309
[TBL] [Abstract][Full Text] [Related]
33. COVID-induced thyroid autoimmunity.
Brancatella A; Viola N; Santini F; Latrofa F
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101742. PubMed ID: 36813660
[TBL] [Abstract][Full Text] [Related]
34. Nervous system-related tropism of SARS-CoV-2 and autoimmunity in COVID-19 infection.
Weissert R
Eur J Immunol; 2024 Jan; 54(1):e2250230. PubMed ID: 37733584
[TBL] [Abstract][Full Text] [Related]
35. Coronavirus-induced autoimmunity.
Salle V
Clin Immunol; 2021 May; 226():108694. PubMed ID: 33610741
[TBL] [Abstract][Full Text] [Related]
36. Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis.
Taghadosi M; Safarzadeh E; Asgarzadeh A; Roghani SA; Shamsi A; Jalili C; Assar S; Soufivand P; Pournazari M; Feizollahi P; Nicknam MH; Asghariazar V; Vaziri S; Shahriari H; Mohammadi A
Rev Med Virol; 2023 Mar; 33(2):e2412. PubMed ID: 36471421
[TBL] [Abstract][Full Text] [Related]
37. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and the clinical course of rheumatic manifestations.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2021 Jul; 40(7):2611-2619. PubMed ID: 33733315
[TBL] [Abstract][Full Text] [Related]
39. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Zapata E; Ramírez-Santana C; Anaya JM
J Infect Dis; 2022 Jun; 225(12):2155-2162. PubMed ID: 35079804
[TBL] [Abstract][Full Text] [Related]
40. The mosaic of autoimmunity - Finally discussing in person. The 13
Mahroum N; Elsalti A; Alwani A; Seida I; Alrais M; Seida R; Esirgun SN; Abali T; Kiyak Z; Zoubi M; Shoenfeld Y
Autoimmun Rev; 2022 Oct; 21(10):103166. PubMed ID: 35932955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
